Home > Boards > US Listed > Medical - Drugs > Lipocine Inc (LPCN)

Well the NASH news is out and the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
gi197845 Member Profile
 
Followed By 4
Posts 2,661
Boards Moderated 1
Alias Born 08/16/16
160x600 placeholder
FCEL, INFI and SIOX among pre market gainers Seeking Alpha - 10/18/2021 8:15:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2021 7:01:27 AM
Lipocine And Antares Pharma Enter Into U.S. Licensing Agreement To Commercialize TLANDO® PR Newswire (US) - 10/18/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/12/2021 3:32:08 PM
Lipocine to Present at The H.C. Wainwright 5th Annual NASH Investor Conference PR Newswire (US) - 10/5/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/28/2021 8:01:20 AM
Lipocine Announces FDA Affirmation Of Class 1 NDA Resubmission For TLANDO® PR Newswire (US) - 9/28/2021 8:00:00 AM
Lipocine to Present at The Cantor Fitzgerald Virtual Global Healthcare Conference PR Newswire (US) - 9/20/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 8:02:02 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2021 5:02:10 PM
Lipocine to Present at The H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire (US) - 9/1/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/25/2021 6:36:12 AM
Lipocine's LPCN 1144 Met Non-Alcoholic Steatohepatitis ("NASH") Resolution Regulatory Endpoint in Phase 2 LiFT Study PR Newswire (US) - 8/25/2021 6:30:00 AM
Lipocine EPS misses by $0.03 Seeking Alpha - 8/5/2021 9:05:16 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2021 8:02:34 AM
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2021 PR Newswire (US) - 8/5/2021 8:00:00 AM
Clarus Therapeutics Announces Comprehensive Settlement of Patent Litigation With Lipocine GlobeNewswire Inc. - 7/15/2021 9:00:00 AM
Lipocine enters settlement and license agreement with Clarus Therapeutics Seeking Alpha - 7/14/2021 4:47:07 PM
Lipocine Announces Settlement With Clarus Therapeutics PR Newswire (US) - 7/14/2021 4:00:00 PM
Lipocine To Present At The Ladenburg Thalmann Healthcare Conference PR Newswire (US) - 7/6/2021 8:00:00 AM
Cantor initiates Lipocine with an overweight rating, sees 121% upside Seeking Alpha - 6/24/2021 11:08:22 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/23/2021 8:02:11 AM
Lipocine Announces Presentations at The International Liver Congress™ 2021 Digital Event PR Newswire (US) - 6/23/2021 8:00:00 AM
Lipocine To Present At The Raymond James Human Health Innovation Conference PR Newswire (US) - 6/16/2021 8:00:00 AM
Lipocine soars 9% on FDA greenlight for Phase 2 LPCN 1154 study in postpartum depression Seeking Alpha - 6/14/2021 8:25:07 AM
gi197845   Thursday, 08/26/21 12:19:10 AM
Re: None
Post # of 759 
Well the NASH news is out and the results are good.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences